// App-Quantinova.ai

SUN-1002 : Use of Long Acting Somatostatin Analog (Lanreotide) in Children with Congenital Hyperinsulinism

Researchers

Presenter

  • Pratik Shah

Principal Investigators

  • Clare Gilbert

  • Kate Morgan

  • Louise Hinchey

  • Syeda Alam

  • Hannah Levy

  • Roberta Button

  • Niamh Landy

  • Rebecca Margetts

  • Senthil Senniappan

  • Khalid Hussain

Medical Centers

  • Great Ormond Street Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Familial hyperinsulinemic hypoglycemia

Biomarkers

  • Hemoglobin A1c

  • Insulin Like Growth Factor Binding Protein 3

  • Insulin-like growth factor 1

  • Somatostatin

Drug/Treatment

  • Lanreotide

  • Somatostatin

  • Octreotide

  • Diazoxide

Outcome

  • N/A

Study Design

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved